Literature DB >> 12640273

Fetal origins of cardiovascular disease.

Michel Baum1, Luis Ortiz, Albert Quan.   

Abstract

Several epidemiologic studies have shown that intrauterine growth retardation is a risk factor for the development of cardiovascular disease in later life. In this review, we discuss these epidemiologic studies and animal models that have been developed to investigate the pathophysiology of this phenomenon. We discuss data suggesting that intrauterine growth retardation leads to fetal exposure to maternal glucocorticoids. In addition, we present other data showing that fetal exposure of glucocorticoids during specific times of fetal development results in focal and segmental glomerulosclerosis, a reduced number of nephrons, hypertension, and diabetes. These studies suggest that at critical times during fetal development fetal injury programs the development of cardiovascular disease and diabetes in later life.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12640273     DOI: 10.1097/00008480-200304000-00005

Source DB:  PubMed          Journal:  Curr Opin Pediatr        ISSN: 1040-8703            Impact factor:   2.856


  9 in total

1.  Developmental neurotoxicity targeting hepatic and cardiac sympathetic innervation: effects of organophosphates are distinct from those of glucocorticoids.

Authors:  Frederic J Seidler; Theodore A Slotkin
Journal:  Brain Res Bull       Date:  2011-03-29       Impact factor: 4.077

Review 2.  Receptor-activating autoantibodies and disease: preeclampsia and beyond.

Authors:  Yang Xia; Rodney E Kellems
Journal:  Expert Rev Clin Immunol       Date:  2011-09       Impact factor: 4.473

3.  Neonatal dexamethasone treatment leads to alterations in cell signaling cascades controlling hepatic and cardiac function in adulthood.

Authors:  Abayomi A Adigun; Nicola Wrench; Frederic J Seidler; Theodore A Slotkin
Journal:  Neurotoxicol Teratol       Date:  2009-10-20       Impact factor: 3.763

Review 4.  Angiotensin receptor agonistic autoantibodies and hypertension: preeclampsia and beyond.

Authors:  Yang Xia; Rodney E Kellems
Journal:  Circ Res       Date:  2013-06-21       Impact factor: 17.367

5.  Chronic Piromelatine Treatment Alleviates Anxiety, Depressive Responses and Abnormal Hypothalamic-Pituitary-Adrenal Axis Activity in Prenatally Stressed Male and Female Rats.

Authors:  Natasha Ivanova; Zlatina Nenchovska; Milena Atanasova; Moshe Laudon; Rumyana Mitreva; Jana Tchekalarova
Journal:  Cell Mol Neurobiol       Date:  2021-05-18       Impact factor: 4.231

6.  The Association between Weight for Gestational Age and Kidney Volume: A Study in Newborns in India.

Authors:  Kirtisudha Mishra; Vikram Datta; Aarushi Aarushi; Maninder Kaur Narula; R Subramanyam Iyer; Sushma Nangia
Journal:  Iran J Pediatr       Date:  2013-01-29       Impact factor: 0.364

7.  Length at birth z-score is inversely associated with an increased risk of bronchopulmonary dysplasia or death in preterm infants born before 32 gestational weeks: A nationwide cohort study.

Authors:  Young Hwa Jung; Youngmi Park; Beyong Il Kim; Chang Won Choi
Journal:  PLoS One       Date:  2019-05-31       Impact factor: 3.240

8.  Postnatal Growth Restriction in Mice Alters Cardiac Protein Composition and Leads to Functional Impairment in Adulthood.

Authors:  Joseph R Visker; Lawrence J Dangott; Eric C Leszczynski; David P Ferguson
Journal:  Int J Mol Sci       Date:  2020-12-12       Impact factor: 5.923

9.  The detrimental role of angiotensin receptor agonistic autoantibodies in intrauterine growth restriction seen in preeclampsia.

Authors:  Roxanna A Irani; Yujin Zhang; Sean C Blackwell; Cissy Chenyi Zhou; Susan M Ramin; Rodney E Kellems; Yang Xia
Journal:  J Exp Med       Date:  2009-11-02       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.